Login / Signup
Priyesh Bipath
ORCID
Publication Activity (10 Years)
Years Active: 2023-2024
Publications (10 Years): 7
Top Topics
Flow Cytometry
Cell Cycle Arrest
Tyrosine Kinase
Electron Microscopy
Top Venues
Clinical and experimental pharmacology & physiology
Cell biochemistry and function
Cancer medicine
Cell biology international
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Charlise Basson
,
Avulundiah Edwin Phiri
,
Manjunath Gandhi
,
Roumen Anguelov
,
June Cheptoo Serem
,
Priyesh Bipath
,
Yvette Nkondo Hlophe
In vitro effects and mathematical modelling of CTCE-9908 (a chemokine receptor 4 antagonist) on melanoma cell survival.
Clinical and experimental pharmacology & physiology
51 (6) (2024)
Charlise Basson
,
June Cheptoo Serem
,
Priyesh Bipath
,
Yvette Nkondo Hlophe
L-kynurenine and quinolinic acid inhibited markers of cell survival in B16 F10 melanoma cells in vitro.
Cell biology international
(2024)
Danielle Sandra Nkandeu
,
Annie Margaretha Joubert
,
June Cheptoo Serem
,
Priyesh Bipath
,
Yvette Nkondo Hlophe
An exploratory study on the effect of kynurenine metabolites on sEnd-2 endothelioma cells.
Cell biochemistry and function
42 (4) (2024)
Charlise Basson
,
Avulundiah Edwin Phiri
,
Manjunath Gandhi
,
Roumen Anguelov
,
June Cheptoo Serem
,
Priyesh Bipath
,
Yvette Nkondo Hlophe
In vitro effects and mathematical modelling of CTCE-9908 (a chemokine receptor 4 antagonist) on melanoma cell survival.
Clinical and experimental pharmacology & physiology
51 (6) (2024)
Charlise Basson
,
June Cheptoo Serem
,
Yvette Nkondo Hlophe
,
Priyesh Bipath
An in vitro investigation of l-kynurenine, quinolinic acid, and kynurenic acid on B16 F10 melanoma cell cytotoxicity and morphology.
Cell biochemistry and function
(2023)
Charlise Basson
,
June Cheptoo Serem
,
Yvette Nkondo Hlophe
,
Priyesh Bipath
The tryptophan-kynurenine pathway in immunomodulation and cancer metastasis.
Cancer medicine
(2023)
Charlise Basson
,
June Cheptoo Serem
,
Priyesh Bipath
,
Yvette Nkondo Hlophe
Chemokines as possible therapeutic targets in metastatic melanoma.
Cancer medicine
(2023)